Tripotassium dicitrato bismuthate on unhealed duodenal ulcers.

Gut. 1988 April; 29(4): 551–552.

PMCID: PMC1433552

F Konikoff

See the reply "Reply" on page 551b.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (154K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bianchi Porro, G; Parente, F; Lazzaroni, M. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers. Gut. 1987 Jul;28(7):907–911. [PubMed]
Marshall, BJ. Campylobacter pyloridis and gastritis. J Infect Dis. 1986 Apr;153(4):650–657. [PubMed]
Rathbone, BJ; Wyatt, JI; Heatley, RV. Campylobacter pyloridis--a new factor in peptic ulcer disease? Gut. 1986 Jun;27(6):635–641. [PubMed]
Hornick, RB. Peptic ulcer disease: a bacterial infection? N Engl J Med. 1987 Jun 18;316(25):1598–1600. [PubMed]
McNulty, CA; Gearty, JC; Crump, B; Davis, M; Donovan, IA; Melikian, V; Lister, DM; Wise, R. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J (Clin Res Ed). 1986 Sep 13;293(6548):645–649. [PubMed]